Biologics

In 1994, a company named Biologics was founded in North Carolina with a focused mission: to improve the lives of people fighting cancer. The company operated as an oncology pharmacy services company, aiming to streamline the fragmented and complex world of cancer care for patients, healthcare providers, and pharmaceutical companies. By managing the distribution of oncology drugs and providing patient support services, Biologics created a more efficient and humane approach to care management. The company established itself as a key player in the specialty pharmacy sector, focusing specifically on oncology and other complex therapeutic areas. This specialization allowed them to develop deep expertise and build strong partnerships. Under the leadership of President and CEO Stuart Frantz, Biologics underwent significant expansion, growing its team by over 400% in the six years leading up to 2016. A pivotal moment in the company's journey came in February 2016, when it was announced that Biologics would be acquired by McKesson Specialty Health, a division of the healthcare giant McKesson Corporation. The acquisition was part of a larger $1.2 billion deal for McKesson that also included Vantage Oncology. For Biologics, this was a historic event that integrated their specialized services into McKesson's vast healthcare platform, promising to serve a wider network of patients and providers.